missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ BNIP2 Polyclonal Antibody

Description
Recommended positive controls: Jurkat, Raji, NCI-H929. Predicted reactivity: Mouse (91%), Rat (92%), Zebrafish (80%), Xenopus laevis (86%), Bovine (97%). Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
BNIP-2, (previously designated Nip2 and Nip21 in human and mouse respectively), shares homology with the non-catalytic domain of Cdc42 GTPase-activating protein (Cdc42GAP). Through binding to Cdc42GAP, BNIP-2 enhances the GTPase activity of Cdc42GAP, facilitating the hydrolysis of GTP bound to Cdc42 and thereby, mediating the signaling pathways involving receptor kinases, small GTPases and apoptotic proteins. Nix, which is also designated Nip3L or Bnip3L, is highly related to BNIP-3, and both proteins localize to the mitochondria where they associate with Bcl-2 proteins.
Specifications
Specifications
| Antigen | BNIP2 |
| Applications | Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry |
| Classification | Polyclonal |
| Concentration | 1.02 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 20% glycerol and 0.025% ProClin 300; pH 7 |
| Gene | Bnip2 |
| Gene Accession No. | Q12982 |
| Gene Alias | 5730523P12Rik; Bcl-2 and E1B 19 kDa interacting protein; BCL2 interacting protein 2; BCL2/adenovirus E1B 19 kDa protein-interacting protein 2; BCL2/adenovirus E1B 19 kDa-interacting protein 2 beta; BCL2/adenovirus E1B 19kDa interacting protein 2; BCL2/adenovirus E1B 19kDa-interacting protein 1, NIP2; BCL2/adenovirus E1B interacting protein 1, NIP2; BCL2/adenovirus E1B interacting protein 2; BNIP 2; BNIP2; BNIP-2; BNIP2beta; NIP2; Nip21; Nip2l |
| Gene Symbols | Bnip2 |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?